COVID-19 frequently causes neurological injuries

Press Release:

Without directly invading the brain or nerves, the virus responsible for COVID-19 causes potentially damaging neurological injuries in about one in seven infected, a new study shows. These injuries range from temporary confusion due to low body-oxygen levels, to stroke and seizures in the most serious cases, say the study authors.

Led by researchers at NYU Grossman School of Medicine, the study showed no cases of brain or nerve inflammation (meningitis or encephalitis), indicating no immediate invasion of these organs by the pandemic virus, SARS-CoV-2.

While this should reassure patients, the neurological complications of COVID-19 should be taken seriously because they dramatically raise a patient’s risk of dying while still in hospital (by 38 percent), researchers say. Such adverse effects also raise a coronavirus patient’s likelihood (by 28 percent) of needing long-term or rehabilitation therapy immediately after their stay in hospital.

“The results of our study showed no signs that the coronavirus directly attacks the nervous system,” says study lead investigator Jennifer Frontera, MD. “The neurological complications seen in COVID-19 are predominately the secondary effects of being severely ill and suffering from low oxygen levels in the body for prolonged periods of time,” says Frontera, a professor in the Department of Neurology at NYU Langone Health.

Published in the journal Neurology online Oct. 5, the study closely monitored the progress of 606 COVID-19 adult patients diagnosed with brain or other nerve-related medical conditions at any of four NYU Langone hospitals in New York City and Long Island between March 10 and May 20, when coronavirus infections were at their peak in the region.

Frontera says that ahead of the pandemic, dozens of NYU Langone neurologists and trainees had deployed across its medical centers to assist with the expectant surge of COVID-19 patients.

Early reports from Asia and Europe, where infections had spiked before rising in the United States, she says, had also “raised the alarm” about possible brain damage from coronavirus infection. Because of this, the research team was ready to look for any signs of neurological dysfunction among the thousands of patients being admitted to hospital in the spring. Among all the hospitals, 4,491 patients tested positive for COVID-19 during that time.

Among the study’s other key results was that common neurological problems, such as confusion caused by chemical electrolyte imbalances, severe infection or kidney failure, usually arose within 48 hours of developing general COVID-19 symptoms, including fever, difficulty breathing, and cough.

Half of those neurologically affected were over the age of 71, which researchers say is significantly older than the other 3,885 patients with COVID-19 (at a media age of 63) who did not experience brain dysfunction. Most were men (66 percent) and white (63 percent). Frontera notes that the study results do suggest that Blacks are not at greater risk of neurological complications than other COVID-19 patients, which is “welcome news,” given that Blacks are widely known to be at greater risk of death from coronavirus infection. However, she says this potentially important observation requires further investigation.

While the coronavirus is known to attack other organs, including blood vessels and the heart, researchers say its main target is the lungs, where it makes breathing difficult, starving the body of oxygen it needs to stay alive. Low levels of oxygen in the body and brain was another common neurological problem, study results showed, that could lead to confusion, coma, or permanent brain damage.

“Our study results suggest that physicians need to be more aggressive in stabilizing body oxygen levels in patients with COVID-19 as a potentially key therapy for stopping, preventing and/or possibly reversing neurological problems,” says study senior investigator Steven Galetta, MD.

###

Galetta, the Philip K. Moskowitz, MD Professor and chair of the Department of Neurology at NYU Langone, says various blood-oxygen-raising therapies that could possibly work against neurological problems in patients with COVID-19 include early intubation or use of heart-lung machines, called ECMO, which mechanically “clean” the blood and “deliver” oxygen into it.

Funding support for the study was provided by National Institutes of Health grant P30 AG066512 and NYU Langone.

Advertisement:

Bestseller No. 1
iHealth COVID-19 Antigen Rapid Test, 1 Pack, 5 Tests Total, FDA EUA Authorized OTC at-Home Self Test, Results in 15 Minutes with Non-invasive Nasal Swab, Easy to Use & No Discomfort
  • Expiration Date Extension: On Jan 11, 2023, the FDA granted another three-month shelf-life extension for the iHealth COVID-19 Antigen Rapid Test, which extended the shelf-life of all iHealth tests from 6 months to 15 months. Please refer to the FDA website for the detailed list of extended expiration dates by lot numbers: https://www.fda.gov/media/164551/download
  • FDA Authorized 15-Minute Self-Test: The test is a 15-minute self-test to detect whether or not an individual has COVID-19. The test can be completed in the comfort of your own home without the need to ship your sample to a lab.
  • Easy to Use with Zero Discomfort: Test can be done by inserting 1/2 to 3/4 inch of a simple non-invasive nasal swab. Step-by-step instructional videos are available in our app (Installation of app is optional).
  • For Ages 2 and Above : The self-administered test is recommended for individuals aged 15 years and older. Adult-collection is required for testing children 2-14 years old.
  • Manage Group Testing Via Mobile App: The iHealth Test app allows the administrator of a small group to monitor and track the group members’ test results as needed at school, work or an event.
SaleBestseller No. 2
BinaxNOW COVID-19 Antigen Self Test, 1 Pack, 2 Tests Total, COVID Test With 15-Minute Results Without Sending to a Lab, Easy to Use at Home
  • #1 COVID-19 SELF TEST IN THE USA: Made with the same reliable technology used by doctors. Detects multiple COVID-19 variants, including Delta and Omicron*
  • FAST RESULTS: At home test with results for you or your family in 15 minutes; no need for a prescription or sending to a lab
  • TRUSTED TECHNOLOGY: Identical to the test used by professionals; intended for personal use with self-reported results and has Emergency Use Authorization from the FDA
  • CONVENIENTLY TEST AT HOME: 2 nasal swab tests are included to detect active infection, with or without symptoms
  • FSA/HSA ELIGIBLE: Test may be reimbursed, depending on coverage; contact your health insurance company to learn more
Bestseller No. 3
iHealth COVID-19 Antigen Rapid Test, 1 Pack, 2 Tests Total, FDA EUA Authorized OTC at-Home Self Test, Results in 15 Minutes with Non-invasive Nasal Swab, Easy to Use & No Discomfort
  • Expiration Date Extension: On Jan 11, 2023, the FDA granted another three-month shelf-life extension for the iHealth COVID-19 Antigen Rapid Test, which extended the shelf-life of all iHealth tests from 6 months to 15 months. Please refer to the FDA website for the detailed list of extended expiration dates by lot numbers: https://www.fda.gov/media/164551/download
  • FDA Authorized 15-Minute Self-Test: The test is a 15-minute self-test to detect whether or not an individual has COVID-19. The test can be completed in the comfort of your own home without the need to ship your sample to a lab.
  • Easy to Use with Zero Discomfort: The test can be done by inserting 1/2 to 3/4 inch of a simple non-invasive nasal swab. Step-by-step instructional videos are available in our app (Installation of the app is optional).
  • For Ages 2 and Above: The self-administered test is recommended for individuals aged 15 years and older. Adult-collection is required for testing children 2-14 years old.
  • Manage Group Testing Via Mobile App: The iHealth Test app allows the administrator of a small group to monitor and track the group members’ test results as needed at school, work, or an event.
SaleBestseller No. 4
Flowflex COVID-19 Antigen Home Test kit, 1 Pack, 5 Tests Total. FDA EUA Authorized OTC at-Home Self-Test, Non-invasive Nasal Swab, Easy to Use and No Discomfort, Results in 15 Minutes
  • Expiration Date Extension: On March 15, 2023, the FDA granted the Flowflex COVID-19 Antigen Home Test another 3-month shelf-life extension, which extended the shelf-life of the product from 12 months to 24 months. Refer to the FDA website for the extended expiration dates.
  • FDA EUA Authorized COVID-19 Home Test – This test is authorized for home use without the need for a prescription or sending to a lab.
  • Detects Active COVID-19 Infection - This test detects multiple COVID-19 variants including the Omicron and Delta variants.
  • Safe to Test Adults and Children – The test is recommended for self-collection by individuals aged 14 years and older and with adult-collection by individuals aged 2 years or older.
  • Easy to Use – All the components of the nasal swab test are included inside the box with step-by-step Instructions for Use in English and Spanish. No Symptoms Needed – This test is intended to test individuals with or without COVID-19 symptoms. Quick Results – This test is quick and simple. The result is read in 15 minutes
Bestseller No. 5
Genabio COVID-19 Test 2 Pack Rapid Self-Test Kit 15 Minute Results, Non-Invasive Short Nasal Swab, Easy to Use, No Discomfort, Quick-Attached Buffer Cap, Covid Home Test 2 Pack (1 Pack, 2 Test Total)
  • OTC Covid Home Test: Conveniently check for Covid-19 from the comfort of your home with this OTC at-home self-test. It uses a non-invasive short nasal swab and delivers results in just 15 minutes. For quick and easy results.
  • Non-Invasive Swab: The test uses a gentle short nasal swab, making it easy and comfortable to administer at home.
  • HSA/FSA Reimbursement Eligible: The test is eligible for HSA/FSA reimbursement, making it more affordable for many people.
  • Trusted by Professionals: The Genabio COVID-19 Rapid Self-Test Kit has been authorized by the FDA for emergency use and is used by healthcare professionals across the US.
  • At-Home Convenience: Avoid the hassle of scheduling an appointment and waiting in line at a testing center by using the Genabio COVID-19 Rapid Self-Test Kit in the comfort of your own home.
SaleBestseller No. 6
Flowflex COVID-19 Antigen Home Test kit, 1 Pack, 2 Tests Total. FDA EUA Authorized OTC at-Home Self-Test, Non-invasive Nasal Swab, Easy to Use and No Discomfort, Results in 15 Minutes
  • Expiration Date Extension: On March 15, 2023, the FDA granted the Flowflex COVID-19 Antigen Home Test another 3-month shelf-life extension, which extended the shelf-life of the product from 12 months to 24 months. Refer to the FDA website for the extended expiration dates.
  • FDA EUA Authorized COVID-19 Home Test – This test is authorized for home use without the need for a prescription or sending to a lab.
  • Detects Active COVID-19 Infection - This test detects multiple COVID-19 variants including the Omicron and Delta variants.
  • Safe to Test Adults and Children – The test is recommended for self-collection by individuals aged 14 years and older and with adult-collection by individuals aged 2 years or older.
  • Easy to Use – All the components of the nasal swab test are included inside the box with step-by-step Instructions for Use in English and Spanish. No Symptoms Needed – This test is intended to test individuals with or without COVID-19 symptoms. Quick Results – This test is quick and simple. The result is read in 15 minutes
Bestseller No. 7
FaStep Rapid 15 Minutes COVID-19 Antigen Home Test (1 Pack, 2 Tests Total)
  • Non-invasive nasal swab, easy to use and convenient for Covid-19 test kit for home use or traveling.
  • Rapid and reliable result in 15 minutes.
  • Nasal test kit designed for user with symptom or without symptom. Detects multiple COVID-19 strains, including the Delta and Omicron variants.
  • This test is authorized for non-prescription home use with self-collected nasal swab specimens from individuals aged 14 years and older or with adult-collected samples from individuals aged 2 years or older.
  • The pack comes with 2 or 4 (Best Value) tests kit. HSA/FSA Eligible.
SaleBestseller No. 8
LUCIRA® by Pfizer COVID-19 & Flu Home Test, Results in 30 Minutes, First and Only At-Home Test for COVID-19 and Flu A/B, Single-Use, Emergency Use Authorized (EUA)
  • THE ONLY 2-in-1 AT-HOME, SINGLE-USE TEST FOR COVID-19 & FLU: Brings the power of lab testing technology to your home. *Packaging may vary
  • FAST, CONVENIENT AT-HOME TESTING: Quickly test for COVID-19 and Flu A/B in the comfort of your home–and get results in 30 minutes
  • EASY 3–STEP TEST FOR AGES 2+: Shallow, anterior nasal swab collection for individuals 14 years or older if self-collected or individuals 2 to 13 years if collected by an adult
  • DEDICATED PFIZER CUSTOMER SUPPORT: For any product questions or issues you may have, including invalid results, please contact our Customer Support team. You can find their number on the back of the box, on the package insert, or at the bottom of our LUCIRA by Pfizer website
  • HSA/FSA ELIGIBLE: Test is HSA/FSA eligible and may be reimbursable by insurance. Contact your health insurance company to learn more
SaleBestseller No. 9
QuickVue At-Home OTC COVID-19 Test, 1 Pack, 2 Tests Total, Self-Collected Nasal Swab Sample, 10 Minute Rapid Results
  • Easy-to-use at-home COVID-19 testing kit provides results in just 10 minutes; non-invasive design makes it easy to gently swab your nose, place in pre-filled tube, and quickly get rapid test results; FDA Emergency Use Authorized and FSA/HSA eligible
  • Home COVID-19 test is quick, simple and designed for self-collected nasal swabs, ages 14 or older; Ages 2+ can be tested if adult collects sample; straightforward results with pink or blue line on test strip
  • At-home COVID-19 screening is for those with or without symptoms and takes approximately 10 minutes; this listing is for 1 test kits. This test kit does not provide a document to present for certain uses, including air travel, re-entry requirements, or testing programs. Please check the requirements for your specific testing needs
  • Each kit includes: 2 individually-wrapped sterile foam swabs in order to test twice over 3 days with at least 24-36 hours between tests, pre-filled tubes (no measuring/counting drops), tube holder, instruction sheet, patient fact sheets
  • How To Use: 1. Swab - Collect a gentle nasal swab sample. 2. Swirl - After adding the swab to the solution tube. 3. Dip - Put the strip into the tube. 4. Read Results - Straightforward and easy-to-read results
SaleBestseller No. 10
Flowflex COVID-19 Antigen Home Test kit, 1 Pack, 1 Tests Total. FDA EUA Authorized OTC at-Home Self-Test, Non-invasive Nasal Swab, Easy to Use and No Discomfort, Results in 15 Minutes
  • Expiration Date Extension: On March 15, 2023, the FDA granted the Flowflex COVID-19 Antigen Home Test another 3-month shelf-life extension, which extended the shelf-life of the product from 12 months to 24 months. Refer to the FDA website for the extended expiration dates.
  • FDA EUA Authorized COVID-19 Home Test – This test is authorized for home use without the need for a prescription or sending to a lab.
  • Detects Active COVID-19 Infection - This test detects multiple COVID-19 variants including the Omicron and Delta variants.
  • Safe to Test Adults and Children – The test is recommended for self-collection by individuals aged 14 years and older and with adult-collection by individuals aged 2 years or older.
  • Easy to Use – All the components of the nasal swab test are included inside the box with step-by-step Instructions for Use in English and Spanish. No Symptoms Needed – This test is intended to test individuals with or without COVID-19 symptoms. Quick Results – This test is quick and simple. The result is read in 15 minutes

I get commissions for purchases made through links on this website. As an Amazon Associate I earn from qualifying purchases.